本页面由Tiger Trade Technology Pte. Ltd.提供服务

Corvus Pharmaceuticals, Inc.

15.04
-0.0700-0.46%
盘后15.040.00000.00%19:11 EDT
成交量:63.25万
成交额:948.25万
市值:12.60亿
市盈率:-28.38
高:15.29
开:15.21
低:14.68
收:15.11
52周最高:26.95
52周最低:3.11
股本:8,376.77万
流通股本:6,719.80万
量比:0.80
换手率:0.94%
股息:- -
股息率:- -
每股收益(TTM):-0.5300
每股收益(LYR):-0.5320
净资产收益率:-32.60%
总资产收益率:-38.36%
市净率:20.58
市盈率(LYR):-28.27

数据加载中...

2021/11/03

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/11/02

重要事件披露

8-K - Current report
2021/11/01

重要事件披露

8-K - Current report
2021/11/01

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/10/22

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/10/05

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/09/30

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/09/23

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/09/22

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/09/22

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/08/04

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/08/02

重要事件披露

8-K - Current report
2021/08/02

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/07/15

重要事件披露

8-K - Current report
2021/06/16

重要事件披露

8-K - Current report
2021/05/11

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/04/29

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/04/29

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/04/29

重要事件披露

8-K - Current report
2021/03/25

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]